News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
62,020 Results
Type
Article (2381)
Company Profile (52)
Press Release (59587)
Section
Business (28644)
Career Advice (40)
Deals (4593)
Drug Delivery (3)
Drug Development (6308)
FDA (1054)
Job Trends (1383)
News (38821)
Policy (1941)
Tag
Academia (99)
Adcomms (3)
Allergies (4)
Alliances (2126)
ALS (7)
Alzheimer's disease (115)
Antibody-drug conjugate (ADC) (5)
Approvals (1085)
Artificial intelligence (26)
Autoimmune disease (2)
Bankruptcy (7)
Best Places to Work (1342)
BIOSECURE Act (2)
Biosimilars (6)
Biotechnology (36)
Bladder cancer (17)
Brain cancer (1)
Breast cancer (40)
Cancer (268)
Cardiovascular disease (19)
Career advice (37)
CAR-T (9)
Cell therapy (24)
Cervical cancer (4)
Clinical research (5541)
Collaboration (49)
Compensation (60)
Complete response letters (2)
COVID-19 (155)
CRISPR (2)
C-suite (14)
Cystic fibrosis (11)
Data (287)
Depression (2)
Diabetes (34)
Diagnostics (648)
Digital health (4)
Drug discovery (9)
Drug pricing (7)
Duchenne muscular dystrophy (6)
Earnings (25588)
Editorial (1)
Events (7375)
Executive appointments (27)
FDA (1246)
Frontotemporal dementia (2)
Funding (35)
Gene editing (3)
Generative AI (2)
Gene therapy (12)
GLP-1 (55)
Government (183)
Guidances (89)
Healthcare (1945)
Immunology and inflammation (5)
Indications (2)
Infectious disease (167)
Inflammatory bowel disease (13)
Influenza (2)
Intellectual property (5)
Interviews (1)
IPO (3496)
Job creations (127)
Job search strategy (36)
Kidney cancer (3)
Labor market (3)
Layoffs (17)
Legal (333)
Liver cancer (10)
Lung cancer (48)
Lymphoma (23)
Machine learning (1)
Manufacturing (13)
MASH (11)
Medical device (1548)
Medtech (1548)
Mergers & acquisitions (1184)
Metabolic disorders (74)
Multiple sclerosis (16)
NASH (2)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (169)
NextGen: Class of 2025 (404)
Non-profit (163)
Now hiring (1)
Obesity (30)
Opinion (2)
Ovarian cancer (12)
Pain (10)
Pancreatic cancer (18)
Parkinson's disease (14)
Patents (11)
Patient recruitment (7)
Peanut (4)
People (1937)
Pharmaceutical (11)
Pharmacy benefit managers (1)
Phase I (1400)
Phase II (2291)
Phase III (2291)
Pipeline (462)
Policy (3)
Postmarket research (222)
Preclinical (446)
Press Release (1)
Prostate cancer (6)
Psychedelics (4)
Radiopharmaceuticals (25)
Rare diseases (36)
Real estate (222)
Regulatory (1571)
Reports (1)
Research institute (97)
Resumes & cover letters (2)
Rett syndrome (1)
RSV (4)
Schizophrenia (8)
Series A (7)
Series B (4)
Service/supplier (2)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (15)
Sponsored (1)
Startups (133)
Stomach cancer (1)
Supply chain (1)
Vaccines (37)
Weight loss (19)
Women's health (1)
Worklife (1)
Date
Today (57)
Last 7 days (249)
Last 30 days (466)
Last 365 days (4223)
2025 (1563)
2024 (4621)
2023 (5247)
2022 (5849)
2021 (6253)
2020 (5742)
2019 (4025)
2018 (3089)
2017 (2722)
2016 (2140)
2015 (2912)
2014 (1811)
2013 (1184)
2012 (1356)
2011 (1659)
2010 (1630)
Location
Africa (55)
Alabama (2)
Alaska (1)
Arizona (14)
Arkansas (1)
Asia (4071)
Australia (768)
California (934)
Canada (263)
China (46)
Colorado (41)
Connecticut (29)
Delaware (30)
Europe (7919)
Florida (115)
Georgia (26)
Idaho (3)
Illinois (49)
India (2)
Indiana (48)
Japan (33)
Kansas (10)
Kentucky (1)
Louisiana (4)
Maine (12)
Maryland (151)
Massachusetts (531)
Michigan (42)
Minnesota (51)
Missouri (6)
Montana (6)
Nebraska (1)
Nevada (8)
New Hampshire (7)
New Jersey (245)
New York (199)
North Carolina (113)
Northern California (419)
Ohio (12)
Oregon (3)
Pennsylvania (193)
Rhode Island (1)
South America (70)
Southern California (356)
Tennessee (7)
Texas (126)
United States (3115)
Utah (27)
Virginia (14)
Washington D.C. (5)
Washington State (125)
Wisconsin (3)
62,020 Results for "92".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Industrial Microbiology Market Size to Capture $24.92 Billion by 2034
February 27, 2025
·
1 min read
Biosimilars
Boehringer Ingelheim Partners With GoodRx to Offer Humira Biosimilar at 92% Discount
In a bid to take advantage of Humira’s slow loss of market share, Boehringer Ingelheim is offering its biosimilar at a 92% discount exclusively to patients who buy the product on GoodRx.
July 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Press Releases
Biologics CDMO Market Size Expected to Reach USD 92.37 Bn by 2034
January 21, 2025
·
1 min read
Press Releases
Biologics CDMO Market Size to Cross USD 92.79 Bn at 15.48% CAGR by 2034, says Healthcare Expert
February 26, 2025
·
1 min read
BioMidwest
LIB Therapeutics Announces Lerodalcibep Abstracts Accepted for Presentation at the 92nd European Atherosclerosis Society Congress
LIB Therapeutics Announces Lerodalcibep Abstracts Accepted for Presentation at the 92nd European Atherosclerosis Society Congress.
May 23, 2024
·
2 min read
Business
Leveragen and 92Bio Forge Strategic Alliance to Advance Therapeutics Using Novel Single Domain Antibody Platform
Leveragen, Inc. announced today that it has entered into a multi-target commercial license agreement with 92Bio, Inc., a biotech firm focused on the development of therapeutic antibodies.
May 28, 2024
·
3 min read
Cell Dissociation Market Hit Robust Growth 13.92% by 2033
The global cell dissociation market size was evaluated at US$ 550 million in 2023 and is expected to attain around US$ 2,003 million by 2033, growing at a CAGR of 13.92% from 2024 to 2033.
April 23, 2024
·
14 min read
Press Releases
Malignant Fibrous Histiocytoma Market Predicted to Grow at a Steady CAGR of 9.2% during 2025-2035, Impelled by Advancements in Diagnostic Techniques
February 4, 2025
·
7 min read
Press Releases
Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company
January 15, 2025
·
5 min read
1 of 6,202
Next
